BAJAJ BROKING
Suven Pharma acquires a 56% stake in NJ Bio for ₹535 crore. The deal expands its addressable market from ₹1,600 crore to ₹11,600 crore.
Suven Pharmaceuticals Limited has acquired a 56% controlling stake in NJ Bio Inc, a US-based CRDMO specialising in antibody-drug conjugates (ADC) and emerging modalities. The ₹535 crore deal bolsters Suven’s position in the global ADC market, currently valued at $2.7 billion (approx ₹22,815 crore), with a projected annual growth rate exceeding 25%. This acquisition marks a strategic move to expand Suven’s addressable market from ₹1,600 crore to ₹11,600 crore.
Also read: Paytm Singapore to Sell SARs in PayPay for ₹2,364 Crore
Investment Value: ₹535 crore for a 56% stake in NJ Bio.
Market Growth: ADC outsourcing market valued at ₹22,815 crore, growing at 25% annually.
Capacity Expansion: ₹124 crore allocated for NJ Bio’s Princeton facility expansion.
Also read: Welspun Corp Secures ₹1,300 Crore US Orders for Coated HSAW Pipes
NJ Bio, headquartered in Princeton, New Jersey, has served over 150 clients, completing more than 500 projects since inception. Its projected 2024 revenue stands at $32 million (approx ₹270 crore), reflecting a 70% CAGR since 2021. The deal includes ₹411 crore for acquiring shares from minority stakeholders and ₹124 crore in primary equity, earmarked for enhancing NJ Bio’s 80,000-square-foot facility.
Key Metrics | Value |
Acquisition Cost | ₹535 crore |
NJ Bio’s 2024 Revenue | ₹270 crore |
ADC Market Size | ₹22,815 crore |
ADC Market Growth Rate | 25% annually |
Addressable Market Expansion | ₹1,600 crore to ₹11,600 crore |
The acquisition aligns with Suven Pharma’s growth strategy, enhancing its capabilities in advanced drug modalities. The deal provides Suven access to NJ Bio’s expertise in ADCs, a high-growth segment, and positions it as a major player in the global CRDMO space.
Suven Pharma’s acquisition of NJ Bio marks a significant milestone in its expansion strategy. The ₹535 crore investment not only increases its global footprint but also significantly enhances its market potential. This move could positively influence the Suven Pharma share price, reflecting investor confidence in its growth trajectory.
Also read: Larsen & Toubro Triumphs in ₹702 Crore Tribunal Case, Customs Demand Quashed
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Indian Overseas Bank Secures ₹1,359 Crore Income Tax Refund for AY 2015-16
11 Dec, 2024 | 2 Min. read
HG Infra Secures ₹899 Crore NH-227B Road Upgrade Project in UP
11 Dec, 2024 | 2 Min. read
NTPC Green Energy Secures 500 MW Solar Project with 250 MW ESS from SECI
11 Dec, 2024 | 2 Min. read
Awfis Space ₹583 Crore Block Deal Launches at ₹680 Floor Price
11 Dec, 2024 | 2 Min. read
Share Market Today | Gift Nifty Hints at Flat Start Amid Mixed Global Cues
11 Dec, 2024 | 4 Min. read
Gold Price in India - Gold Prices Edge Higher as Futures Hit $2,654.50
10 Dec, 2024 | 40 Min. read
Metropolis Healthcare Acquires Core Diagnostics for ₹246.83 Crore
10 Dec, 2024 | 2 Min. read
Vodafone Idea to Issue Shares Worth ₹1,980 Crore at 39% Premium
10 Dec, 2024 | 2 Min. read
Tata Motors To Increase Passenger Vehicle Prices By Up To 3% From January
10 Dec, 2024 | 2 Min. read
Share Market Today | Gift Nifty Signals Flat To Positive Start For Markets
10 Dec, 2024 | 4 Min. read
Syngene International Block Deal: Biocon to Sell 2% Stake at ₹825 per Share
10 Dec, 2024 | 2 Min. read
Know Supreme Facility Management IPO Objective & Investment Guide
10 Dec, 2024 | 4 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading